Pharmacy PGY2 Oncology Residency
The Division of Pharmacy at The University of Texas MD Anderson Cancer Center offers an ASHP accredited one-year PGY2 Oncology Pharmacy Residency Program. MD Anderson has more than 700 inpatient beds and over 5000 outpatient clinic visits daily. Residents completing the program will become competent and confident in the practice of oncology pharmacy. Residents will be accountable for achieving optimal drug therapy outcomes as an integral member of interdisciplinary health care teams while striving to improve the overall medication use process. They will exercise skill in oncology pharmacy operations, drug information, investigational pharmacy services, clinical research and writing, and providing education to health care professionals, patients, and the general public. Graduates of the program will be prepared to provide clinical pharmacy services for oncology, malignant hematology, and stem cell transplant patient populations in both the acute and ambulatory care settings.
Qualifications
Required: Pharm.D. degree from an accredited school of pharmacy and completion of an ASHP-accredited PGY1 Pharmacy Residency Program. Texas Pharmacist licensure is required no later than October 1.
For questions regarding the program or application process, please contact Morgan Mace, Pharm.D., BCOP via email at PGY2-OncologyResidency@mdanderson.org or phone 713-563-0720.
Our PGY2 Oncology Pharmacy Residents
Charles Burke, Pharm.D.
Pharmacy School: University of Florida, Gainesville, FL
PGY1 Residency: UT MD Anderson Cancer Center, Houston, TX
Email: ceburke@mdanderson.org
Pui Shan Chu, Pharm.D. BCPS
Pharmacy School: Mercer University, Atlanta, GA
PGY1 Residency: Beaumont Hospital, Royal Oak, MI
Email: pchu1@mdanderson.org
Asha Patel, Pharm.D.
Pharmacy School: Texas Southern University, Houston, TX
PGY1 Residency: UT MD Anderson Cancer Center, Houston, TX
Email: aapatel2@mdanderson.org
Ryan Scanlan, Pharm.D.
Pharmacy School: Temple University, Philadelphia, PA
PGY1 Residency: UT MD Anderson Cancer Center, Houston, TX
Email: rscanlan@mdanderson.org
Residency Overview
- Deadline for application – January 5
- Application materials must be submitted via PhORCAS™
- Pre-screening interview is required prior to application submission - Email the residency program director and attach CV to request a pre-screening interview. The deadline for making contact is one week after the end of the ASHP Midyear Clinical Meeting.
- Interview required (dates to be determined)
- Start date: mid-July
- Annual salary $65,000
- Benefits include 160 hours of leave for personal time off and conference attendance, 100 hours of sick leave, medical insurance, medical library, medical graphics department, information technology support, office with dedicated computer and references
- Meetings funded may include ASHP Midyear Clinical Meeting, Hematology/Oncology Pharmacy Association (HOPA) Annual Meeting
- Numerous board-certified preceptors
- Diverse hematology/oncology learning experiences with tailored instruction for the individual resident based on interests and career goals
- Research project required to be completed with poster presentation at the HOPA Annual Meeting
- Professional presentations: Pharmacy Grand Rounds (ACPE), Oncology Forum, shared student instruction
- Weekend coverage: approximately 12-15 weekends per year
- Teaching certificate program (optional)
Program Design and Resident Responsibilities
Learning experiences are scheduled as 3-5 week experiences or in a longitudinal experience format. Residents are required to meet with the preceptor(s) prior to starting each learning experience to review the goals/objectives and expectations of the learning experience. The resident’s daily responsibilities will be under the direction of the assigned preceptor.
Required clinical learning experiences include:
- Inpatient-focused learning experiences
- Adult Leukemia
- Lymphoma/Myeloma
- Stem Cell Transplant
- Outpatient-focused learning experiences
- Breast Medical Oncology
- Gastrointestinal Medical Oncology
- Genitourinary Oncology
- Gynecology Oncology
- Thoracic Medical Oncology
- Combination of inpatient and outpatient learning experiences
- Melanoma Medical Oncology
- Electives (2) – Pediatrics, Palliative care, Sarcoma, Investigational Cancer Therapeutics, Neuro-oncology, Outpatient Stem Cell Transplant, Outpatient Leukemia or Lymphoma, Infectious Disease, Inpatient CAR-T, Head & Neck Medical Oncology and others
- While on clinical learning experiences, residents will participate in direct patient care activities (rounding, clinic, medication education, etc.) and scheduled topic discussions. Residents will actively work with an assigned preceptor.
- Residents will gain experience with malignant hematology and solid tumor disease states in the inpatient and outpatient settings during the residency year.
Other Required Learning Experiences
- Investigational Pharmacy Services
- Investigational protocol review
- Development of drug information forms for investigational agents
- IRB or Clinical Research Committee meeting attendance
- Professional Pharmacy Practice
- Participation on the Clinical Medication Safety Committee, which helps to track, review, and report all safety events involving clinical pharmacy staff.
- Participation in the development or review of policies and procedures, treatment plans, medication guidelines, treatment algorithms, or other project related to our electronic health record.
- Professional development discussions - all PGY2 residents will participate in longitudinal discussions aimed at facilitating professional development in clinical practice. A variety of preceptors and employees of the Division of Pharmacy will participate in each discussion in order to share different experiences and viewpoints. Examples of these discussions include self-evaluation/professionalism/emotional intelligence/credibility, precepting and mentorship, technology and automation, and pharmacy administration.
Weekend/Holiday Coverage
Residents will provide operations staffing in the Ambulatory Treatment Center (ATC), which will include order entry and verification, as well as chemotherapy preparation. Residents will be assigned to work approximately 12-15 weekends throughout the year, including Thanksgiving or Christmas (but not both) and 1-2 minor holidays throughout the year. During selected weekends, residents will also provide coverage for the non-formulary on call service.
Research Project
The research project is an ASHP requirement and must be completed prior to completion of the residency program. The project may be administrative, clinical, or quality improvement in focus. A minimum of one preceptor will be assigned to each project to help ensure appropriateness and completion. The project should be appropriate for publication and will be presented at the HOPA annual meeting. Documentation of the research project will include a project description (including background, objectives, methods, and resident's responsibilities) and a final project manuscript complete with results, data analysis, and conclusions.
Presentations and Teaching Opportunities
- Oncology Forum
- Oncology forum is held every Tuesday and is attended by pharmacy residents, clinical staff, staff pharmacists, pharmacy students and other health care professionals/trainees. It is designed for residents to facilitate a review and discussion on supportive care topics, chemotherapy agents by class, and cancer disease states. One resident is assigned to each topic and provides an overview of the topic in a discussion format, including a handout. Clinical staff help the resident facilitate the discussion.
- Grand Rounds
- Each resident is required to present a Grand Rounds to the Division of Pharmacy complete with continuing pharmacy education accreditation (ACPE). This is a formal presentation complete with Audience Response System (ARS) questions, slides, and handout. The audience is primarily pharmacists, but it is open to other health professionals. The resident will select a presentation topic of interest to him/her based on the needs assessment that was conducted per ACPE requirements. Each resident will work with a minimum of one preceptor. The preceptor’s responsibility is to serve as a content expert by reviewing and revising presentation content as well as ensuring deadlines are met by the resident.
- Education program to general public regarding cancer screening & prevention
- Residents will participate in the development and delivery of a program for the general public that centers on health improvement, wellness, and screening for and preventing cancer. Residents may accomplish this in a variety of ways: the MD Anderson Ambassador program, participation in health fairs, Cancer Survivors Week, providing education at an appropriate venue, etc. Residents will be responsible for identifying appropriate activities and developing education materials and should work together to meet the goal/objectives. Each resident will participate in at least 1 event during the course of the residency year.
- Nursing Inservices
- Residents will gain experience providing education and/or training to health care professionals by providing nursing inservices. Inservices will be assigned to specific clinical learning experiences. Topics may be chosen by the resident or assigned by the preceptor and must be a minimum of 30 minutes in duration.
- Student Teaching Activities
- All residents will participate in teaching in Shared Student Instruction, which consists of leading an assigned topic discussion with pharmacy school students on rotation at MD Anderson during each student block (a minimum of 3 times/year).
- All residents will participate in leading Shared Student Journal Club and Presentations (SSJCP), which allows for pharmacy students to critically evaluate and discuss recent articles with their peers, residents, and clinical pharmacy specialists during their APPE rotations at MD Anderson. All residents will also participate in case presentations, where pharmacy students have the opportunity to deliver a formal presentation in front of an audience of peers, residents, and clinical pharmacy specialists on a topic of their choosing.
- Residents may have the opportunity to participate in the oncology module for the University of Houston, College of Pharmacy Therapeutics Course by giving a didactic lecture or facilitating case conferences.
Teaching Certificate Program
The University of Houston College of Pharmacy offers a teaching certificate program to all pharmacy residents in the Houston area. The purpose of the program is to provide a formal training program for pharmacy residents to gain knowledge and to demonstrate effectiveness in the areas of teaching, leadership and scholarship. The program consists of three components: 1) Weekly Seminars 2) Teaching Experience 3) Teaching Portfolio. This is an elective learning activity (not required).
Conference/Seminar Attendance
Residents may attend the following conferences: ASHP Midyear Meeting and HOPA (Hematology/Oncology Pharmacy Association). Residents may attend other conferences designated by the program director.
PGY2 Oncology Pharmacy Residency Preceptors
Residency Program Director
Morgan Mace, Pharm.D., BCOP
Director, PGY2 Oncology Pharmacy Residency Program
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training: Pharm.D., The University of South Carolina College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, UF Health Shands Hospital
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Residency Program Coordinators
Katie Highsmith, Pharm.D., BCOP
Coordinator, PGY2 Oncology Pharmacy Residency Program
Clinical Pharmacy Services Manager
Clinical Pharmacy Specialist – Neuro-oncology
Training: Pharm.D., University of the Pacific, Thomas J. Long School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, VA San Diego Healthcare System
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Adam DiPippo, Pharm.D., BCOP
Coordinator, PGY2 Oncology Pharmacy Residency Program
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., MCPHS University
ASHP-Accredited PGY1 Pharmacy Residency, Concord Hospital
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Breast Medical Oncology Preceptors
Bonnie Boster, Pharm.D., BCOP
Clinical Pharmacy Specialist – Breast Medical Oncology
Training: Pharm.D., The Ohio State University
ASHP-Accredited PGY2 Oncology, South Texas Veterans Health Care System
Seena Cherian, Pharm.D.
Clinical Pharmacy Specialist – Breast Medical Oncology
Training: Pharm.D., St. Louis College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, University of North Carolina Med Center
ASHP-Accredited PGY2 Oncology, Memorial Sloan Kettering Cancer Center
Erin Grannan, Pharm.D., BCOP
Clinical Pharmacy Specialist – Breast Medical Oncology
Training: Pharm.D., Philadelphia College of Pharmacy at the University of Health Sciences
ASHP-Accredited PGY1 Pharmacy Residency, MedStar Washington Hospital Center
ASHP-Accredited PGY2 Oncology, Dana-Farber Cancer Institute
Jaime Kaushik, Pharm.D., BCOP
Clinical Pharmacy Specialist – Breast Medical Oncology
Training: Pharm.D., University of Iowa College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, University of Illinois at Chicago
ASHP-Accredited PGY2 Oncology, University of Illinois at Chicago
Jon Malara, Pharm.D., BCOP
Clinical Pharmacy Specialist – Breast Medical Oncology
Training: Pharm.D., Philadelphia College of Pharmacy at the University of Health Sciences
ASHP-Accredited PGY1 Pharmacy Residency, Robert Wood Johnson University Hospital
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Alicia McGhie, Pharm.D., BCOP
Clinical Pharmacy Specialist – Breast Medical Oncology
Training: Pharm.D., University of California, San Diego Skaggs School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Swedish Medical Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Neelam Patel, Pharm.D., BCOP
Clinical Pharmacy Service Manager
Clinical Pharmacy Specialist – Breast Medical Oncology
Training: Pharm.D., Mercer University College of Pharmacy and Health Sciences
ASHP-Accredited PGY1 Pharmacy Residency, Memorial University Medical Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
John Patrick (JP) Sanchez, Pharm.D., BCOP
Clinical Pharmacy Specialist – Breast Medical Oncology
Training: Pharm.D., The University of Texas at Austin College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Abigail Shockley, Pharm.D., BCOP
Clinical Pharmacy Specialist – Breast Medical Oncology
Training: Pharm.D., Purdue University College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Medical University of South Carolina
ASHP-Accredited PGY2 Oncology, Medical University of South Carolina
Gastrointestinal Medical Oncology Preceptors
Neha Betrabet, Pharm.D.
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training: Pharm.D., UT Austin College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, University of Illinois - Chicago
ASHP-Accredited PGY2 Oncology, The University of Kansas Health System
Wendy Covert, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training: Pharm.D., University of Houston College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, The Methodist Hospital
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Stacy Diao, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training: Pharm.D., The University of Kansas
ASHP-Accredited PGY1 Pharmacy Residency, Baylor University Medical Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Joe Fang, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training: Pharm.D., The University of Texas at Austin College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Andrea Landgraf Oholendt, Pharm.D., BCOP
Clinical Pharmacy Service Manager
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training: Pharm.D., The University of Arizona College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, The Methodist Hospital
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Michael Leung, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training: Pharm.D., University of Maryland School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Jane Rogers, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training: Pharm.D., West Virginia University
ASHP-Accredited PGY1 Pharmacy Residency, West Virginia University Hospitals
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Amanda Sirisaengtaksin, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training: Pharm.D., Texas A&M College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Baylor St. Luke’s Medical Center
ASHP-Accredited PGY2 Oncology, Henry Ford Health System
Makenna Smack, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training: Pharm.D., Roseman University of Health Sciences College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Memorial Hermann Hospital System
ASHP-Accredited PGY2 Oncology, Boston Medical Center
Jennifer Zadlo, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training: Pharm.D., The Univ. of the Sciences in Philadelphia – Philadelphia College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Penn State Milton S. Hershey Med. Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Genitourinary Medical Oncology Preceptors
Henry Cao, Pharm.D., BCPS
Clinical Pharmacy Specialist – Genitourinary Medical Oncology
Training: Pharm.D., University of Houston College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
Diana Cauley, Pharm.D., BCOP
Clinical Pharmacy Specialist – Genitourinary Medical Oncology
Training: Pharm.D., University of Colorado, Health Science Center
ASHP-Accredited PGY1 Pharmacy Residency, University of California, San Francisco
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Adrienne Chen, Pharm.D., BCPS
Clinical Pharmacy Specialist – Genitourinary Medical Oncology
Training: Pharm.D., The University of Texas at Austin
ASHP-Accredited PGY1 Pharmacy Residency, Michael E. DeBakey VA Medical Center
Allison Grana, Pharm.D., BCOP
Clinical Pharmacy Specialist – Genitourinary Medical Oncology
Training: Pharm.D., Purdue University
ASHP-Accredited PGY1 Pharmacy Residency, The Johns Hopkins Hospital
ASHP-Accredited PGY2 Oncology, The James Cancer Hospital at The Ohio State Univ.
Anna Jan, Pharm.D., BCOP
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training: Pharm.D., University of California San Francisco, School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, VA Greater Los Angeles Healthcare System
ASHP-Accredited PGY2 Oncology, H. Lee Moffitt Cancer Center
Emily Wang, Pharm.D., BCOP
Clinical Pharmacy Specialist – Genitourinary Medical Oncology
Training: Pharm.D., Texas Tech University Health Science Center – School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, CHI St. Luke’s Health System
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Gynecologic Oncology Preceptors
Donyika Joseph, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gynecologic Oncology
Training: Pharm.D., Xavier University School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Our Lady of the Lake Regional Med. Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Shrina Patel, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gynecologic Oncology
Training: Pharm.D., University of the Sciences in Philadelphia
ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Investigational Cancer Therapeutics Preceptors
Stacie Bean, Pharm.D.
Clinical Pharmacy Specialist – Investigational Cancer Therapeutics
Training: Pharm.D., Xavier University of Louisiana
ASHP-Accredited PGY1 Pharmacy Residency, St. Claire Regional Medical Center
ASHP-Accredited PGY2 Oncology, Emory University Hospital
JoAnn Lim, Pharm.D., BCOP
Clinical Pharmacy Specialist – Investigational Cancer Therapeutics
Training: Pharm.D., The Ohio State University
ASHP-Accredited PGY1 Pharmacy Residency, The Ohio State Univ. Hospital and Clinics
ASHP-Accredited PGY2 Oncology, The Ohio State Univ. Arthur G. James Cancer Center
Hoyt Slade, Pharm.D., BCOP, CMTM
Clinical Pharmacy Specialist – Investigational Cancer Therapeutics
Training: Pharm.D., Mercer University Southern School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, UAB Health System
ASHP-Accredited PGY2 Oncology, UAB Health System
Leukemia Preceptors
Jeff Bryan, Pharm.D.
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., University of Georgia, College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Univ. of Alabama at Birmingham Hospital
ASHP-Accredited PGY2 Oncology, University of Alabama at Birmingham Hospital
Emily Gunter, Pharm.D.
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., University Houston College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Emily Lee, Pharm.D.
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., Purdue University College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Grady Health System in Atlanta, GA
ASHP-Accredited PGY2 Oncology, Grady Health System in Atlanta, GA
Alexandra Lovell, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., University of Iowa College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Carolinas Medical Center
ASHP-Accredited PGY2 Oncology, Barnes-Jewish Hospital
Kayleigh Marx, Pharm.D., BCOP
Clinical Pharmacy Services Manager
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., The University of Georgia College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, University of Kentucky HealthCare
ASHP-Accredited PGY2 Oncology, University of Kentucky HealthCare
Mikaela McCabe, Pharm.D.
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., University of Kansas School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Barnes-Jewish Hospital
ASHP-Accredited PGY2 Oncology, Barnes-Jewish Hospital
Debbie McCue, Pharm.D., BCOP
Clinical Pharmacy Services Manager
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., University of Maryland School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Bronx VAMC
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Dan Nichols, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., Virginia Commonwealth University
ASHP-Accredited PGY1 Pharmacy Residency, University of Kentucky HealthCare
ASHP-Accredited PGY2 Oncology, University of Kentucky HealthCare
Grace Park, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., University of Houston College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Houston Methodist Hospital
ASHP-Accredited PGY2 Oncology, Dana Farber Cancer Institute
Shilpa Paul, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., University of Illinois at Chicago – College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Yale-New Haven Hospital
ASHP-Accredited PGY2 Oncology, Huntsman Cancer Institute
Michael Savoy, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., University of Louisiana at Monroe College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, The Johns Hopkins Hospital
ASHP-Accredited PGY2 Oncology, The Johns Hopkins Hospital
Austin Wilson, Pharm.D., BCPS, BCCCP, BCEMP
Clinical Pharmacy Specialist – Leukemia
Training: Pharm.D., University of Kansas School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Banner University Medical Center Tucson
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Lymphoma – Myeloma Preceptors
Sheree Chen, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training: Pharm.D., The University of Texas at Austin College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Texas Tech Univ. Health Sciences
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Ashley Dinh, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training: Pharm.D., University of Texas at Austin College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Bryan Do, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training: Pharm.D., Regis University School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, UMass Memorial Medical Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Robyn Feldman, Pharm.D., BCPS, BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training: Pharm.D., Midwestern University (Chicago College of Pharmacy)
ASHP-Accredited PGY1 Pharmacy Residency, Baptist Hospital of Miami
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Sandy Horowitz, Pharm.D.
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training: Pharm.D., St. John’s University, College of Pharmacy and Allied Health Professions
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Benjamin Lee, Pharm.D., BCPS, BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training: Pharm.D., University of North Carolina Eshelman School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Moffitt Cancer Center
ASHP-Accredited PGY2 Oncology, Moffitt Cancer Center
Caitlin Linger, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training: Pharm.D., The Ohio State University College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Brian Primeaux, Pharm.D., BCOP
Clinical Pharmacy Services Manager
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training: Pharm.D., University of Louisiana at Monroe
ASHP-Accredited PGY1 Pharmacy Residency, The Johns Hopkins Hospital
ASHP-Accredited PGY2 Oncology, The Johns Hopkins
Mohammad Waleed, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training: Pharm.D., University of Connecticut School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Johns Hopkins Bayview Medical Center
ASHP-Accredited PGY2 Oncology, Dartmouth-Hitchcock Medical Center
Erin Yeung, Pharm.D., BCPS, BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training: Pharm.D., The University of Texas at Austin College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, South Texas Veterans Health Care System
ASHP-Accredited PGY2 Oncology, South Texas Veterans Health Care System
Melanoma and Sarcoma Preceptors
Jaime Anderson, Pharm.D., BCOP
Clinical Pharmacy Services Manager
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training: Pharm.D., University of Colorado at Denver School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Cleveland Clinic
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Megan Fonteno, Pharm.D.
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training: Pharm.D., Auburn University
ASHP-Accredited PGY1 Pharmacy Residency, Piedmont Columbus Regional Hospital
ASHP-Accredited PGY2 Oncology, Huntsman Cancer Institute at the University of Utah
Michael Frei, Pharm.D., BCOP
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training: Pharm.D., Wayne State University
ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Emma Garrison, Pharm.D., BCOP
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training: Pharm.D., University of Florida College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, UF Health Shands Hospital
ASHP-Accredited PGY2 Oncology, UF Health Shands Hospital
Jocelyn Joseph, Pharm.D., BCOP
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training: Pharm.D., The University of Texas at Austin College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Methodist Healthcare – University Hospital
ASHP-Accredited PGY2 Oncology, The University of Kansas Hospital
Van Trinh, Pharm.D., BCOP
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training: Pharm.D., University of Houston College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Hermann Hospital
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Neuro-Oncology Preceptors
Aqsa Adnan, Pharm.D., BCOP
Clinical Pharmacy Specialist – Neuro-Oncology
Training: Pharm.D., Xavier University School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Our Lady of the Lake Regional Med. Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Pediatric Oncology Preceptors
Suzanne Gettys, Pharm.D., BCOP
Clinical Pharmacy Specialist – Pediatric Oncology
Training: Pharm.D., Mercer College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Emory University Hospital Midtown
ASHP-Accredited PGY2 Oncology, Emory University Hospital Midtown
Estela Mireles, Pharm.D., BCOP
Clinical Pharmacy Specialist – Pediatric Oncology
Training: Pharm.D., Texas Tech University Health Sciences Center School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, The University of Texas Medical Branch
ASHP-Accredited PGY2 Oncology, St. Jude Children’s Research Hospital
Lindsay Robusto, Pharm.D., BCOP
Clinical Pharmacy Specialist – Pediatric Oncology
Training: Pharm.D., University of New England College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Johns Hopkins Bayview Medical Center
ASHP-Accredited PGY2 Oncology, The Johns Hopkins Hospital
Stem Cell Transplantation and Cellular Therapy Preceptors
Telyssa Anderson, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training: Pharm.D., Texas Tech Health Sciences Center School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, WVU Medicine
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Trace Bartels, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training: Pharm.D., University of Arizona College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Mayo Clinic Hospital
ASHP-Accredited PGY2 Oncology, Moffitt Cancer Center
Morgan Belling, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training: Pharm.D., Ohio Northern University – Rudolph H. Raabe College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, WVU Medicine
ASHP-Accredited PGY2 Oncology, WVU Medicine
Rita Cool, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training: Pharm.D., The University of Texas at Austin College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Scott & White Memorial Hospital
ASHP-Accredited PGY2 Oncology, Scott & White Memorial Hospital
Vi Doan, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training: Pharm.D., University of Houston College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Jill Ferguson, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training: Pharm.D., The University of Texas Health Science Center at San Antonio
ASHP-Accredited PGY2 Oncology, Audie L Murphy Veterans Hospital
Bradley Figgins, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training: Pharm.D., University of Florida College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Alison Gulbis, Pharm.D., BCOP
Clinical Pharmacy Services Manager
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training: Pharm.D., University of Florida College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Medical University of South Carolina
ASHP-Accredited PGY2 Oncology, Medical University of South Carolina
Suhani Mehta, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training: Pharm.D., Purdue University College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Northwestern Memorial Hospital
ASHP-Accredited PGY2 Oncology, Cleveland Clinic
Terri Lynn Shigle, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training: Pharm.D., Ohio Northern University
ASHP-Accredited PGY1 Pharmacy Residency, UPMC Mercy
ASHP-Accredited PGY2 Oncology, UPMC Shadyside
Whitney Wallis, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training: Pharm.D., University of Tennessee Health Sciences Center School of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, Methodist University Hospital
ASHP-Accredited PGY2 Oncology, UAB Hospital
Thoracic / Head and Neck Medical Oncology Preceptors
Whitney Lewis, Pharm.D., BCOP
Clinical Pharmacy Specialist – Thoracic / Head and Neck Medical Oncology
Training: Pharm.D., University of Oklahoma College of Pharmacy
ASHP-Accredited PGY1 Pharmacy Residency, St. John Medical Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Melvin Rivera, Pharm.D., BCOP
Clinical Pharmacy Specialist – Thoracic / Head and Neck Medical Oncology
Training: Pharm.D., Northeastern University, Bouve College of Health Sciences
ASHP-Accredited PGY1 Pharmacy Residency, Boston Medical Center
ASHP-Accredited PGY2 Oncology, Boston Medical Center
Joelyann Valles Rivera, Pharm.D., BCPS, BCOP
Clinical Pharmacy Specialist – Thoracic / Head and Neck Medical Oncology
Training: Pharm.D., Nova Southeastern University, San Juan, PR
ASHP-Accredited PGY1 Pharmacy Residency, Jackson Memorial Hospital
ASHP-Accredited PGY2 Oncology, Baptist MD Anderson Cancer Center, Jacksonville
Karen Wang, Pharm.D., BCOP
Clinical Pharmacy Specialist – Thoracic / Head and Neck Medical Oncology
Training: Pharm.D., Rutgers University
ASHP-Accredited PGY1 Pharmacy Residency, Iowa Methodist Medical Center
ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center
Frequently Asked Questions
What is the goal of the residency?
The goal of the PGY2 Oncology Pharmacy Residency Program is to provide the resident with a broad-based exposure and experience with malignant hematology, oncology, and stem cell transplant patient populations. The resident will develop their clinical skills and be prepared to provide clinical pharmacy services in both the acute and ambulatory care settings.
How is the residency offered?
The residency is a one-year program that is heavily weighted in direct patient care. The program consists of core learning experiences and additional requirements but allows for tailored instruction on each individual resident’s interest(s) and career goals.
Is the program accredited by the American Society of Health-System Pharmacists?
Yes, the program received a full-cycle (8 year) re-accreditation by the Commission on Credentialing of the American Society of Health-System Pharmacists in 2018.
Is participation in the ASHP match program required?
Participation in the ASHP match program is required. The ASHP Resident Matching Program code for the MD Anderson Oncology Residency Program is 584060. Please review match requirements and process at www.natmatch.com. For details regarding the residency application process, please visit www.mdanderson.org/pharmacy. The deadline for application submission is January 5.
How many resident positions are available and what are the requirements?
We currently offer 4 PGY2 Oncology Pharmacy Resident positions each year. Requirements include a Pharm.D. degree, successful completion of an ASHP-accredited PGY1 Pharmacy Residency, and Texas Pharmacist licensure no later than October 1.
What should I expect at the time of the interview?
The interview process entails a full day (approximately 8:00 a.m.-4:00 p.m.) of meetings with clinical preceptors, program leadership, and current residents. During the interview, candidates will also work-up a patient case that is presented to a group of program preceptors. The purpose of the patient case is to evaluate the candidate’s knowledge base, clinical decision-making skills, and communication skills. More information regarding interview format and process will be provided prior to the interview. Interviews will be conducted in February.
How are residents selected for the residency?
Residents are selected by the Division of Pharmacy based on multiple factors including their past education and training, letters of reference, performance during the interview, and overall match with the PGY2 Oncology Residency Program at MD Anderson. The program director will discuss the matching process and notification of resident selection during the interview.
Does the resident need to be licensed in the state of Texas?
The resident must be eligible for pharmacist licensure in the state of Texas (reciprocity or examination) as soon as they are accepted into the program. It is highly recommended that the resident completes all necessary examinations / processes for licensure prior to starting the program in July. It is mandatory that the resident is licensed by the Texas State Board of Pharmacy by October 1 in order to successfully complete the program.
Who is the PGY2 Oncology Residency Program Director and who are the preceptor faculty?
The director of the PGY2 Oncology Pharmacy Residency is Morgan Mace, Pharm.D., BCOP. The residency coordinators are Katie Highsmith, Pharm.D., BCOP, and Adam DiPippo, PharmD, BCOP. In addition to the Division of Pharmacy and program leadership, there are numerous board certified clinical pharmacy specialists who serve as preceptors for the PGY2 Oncology Pharmacy Residency. This includes specialists in each of the oncology disease sites, drug information, medication safety, investigational pharmacy services, infectious diseases, and pharmacy operations. The preceptor group is dedicated and committed to the continued success of each of our residents and the program overall.
What expectations are placed on the resident?
The resident is expected to make a commitment to satisfactorily complete all requirements of the program, as planned in advance and communicated with the resident upon acceptance into the program. This commitment includes but is not limited to the following: active participation in direct patient care, presentations, weekend coverage, research and other projects as assigned, attendance at required meetings and programs, and the availability and willingness to participate in any function of the Division of Pharmacy on a 24-hour basis. The resident is required to complete documentation and evaluations for all activities, experiences, and objectives accomplished. The resident must meet the criteria of “achieved for residency” for a pre-specified number of goals/objectives in order to successfully complete the program.
What are the service commitments?
In addition to scheduled and elective learning experiences, the resident is required to participate in weekend coverage providing pharmacy operations staffing in the Ambulatory Treatment Center (ATC). Each resident will be scheduled to work approximately 12-15 weekends, including the possibility of one major holiday (Thanksgiving or Christmas) and 1-2 minor holidays. Residents will also participate in non-formulary on call intermittently when providing weekend coverage.
What presentations and publications are expected of the resident?
Throughout the year, the resident will provide 8-10 Oncology Forum presentations, and one program on cancer screening and prevention to the general public. Each resident is required to present a Pharmacy Grand Rounds complete with continuing pharmacy education (ACPE) credit. Residents will be expected to present their research project results as a poster presentation at the annual HOPA (Hematology/Oncology Pharmacy Association) meeting.
How is the resident evaluated?
The PGY2 Oncology pharmacy residency program at MD Anderson is not based upon a set number of "hours" in each experience area. Rather, it is based upon behavioral plus competency-based objectives. During each learning experience, preceptor faculty will provide the resident with weekly informal feedback as well as a formal summative evaluation upon completion of the rotation according to the pre-assigned goals and objectives. Longitudinal learning experiences are evaluated quarterly. Additionally, the resident will evaluate their preceptor and the learning experience upon completion of each individual experience. All learning experience evaluations are documented and maintained in PharmAcademic. Upon completion of the residency program, the resident will be asked to evaluate the overall residency program (i.e., strengths, weaknesses) as well as to provide suggestions for improvement.
What support is offered for educational trips and seminars?
Every attempt is made to financially support travel for the residents to attend relevant educational seminars and programs. Priority programs include ASHP Midyear and HOPA (Hematology/Oncology Pharmacy Association) Annual Meeting.
In what other educational programs does the Division of Pharmacy participate?
The Division of Pharmacy provides case-based Shared Student Instruction and Shared Student Journal Club and Presentations for fourth year pharmacy students completing rotations at MD Anderson (approximately three times/year). Didactic lecture opportunities and a teaching certificate program (both elective) are available through the University of Houston College of Pharmacy. The Division of Pharmacy provides inservice and continuing education programs to the hospital's professional staff. The Division of Pharmacy also offers additional residency programs, including a PGY1 Pharmacy Residency, PGY2 Critical Care Pharmacy Residency, PGY2 Infectious Diseases, PGY2 Medication-Use Safety & Policy, and PGY1/PGY2 Health System Pharmacy Administration Residency.
What stipend and benefit program is offered?
The annual stipend is $65,000. The benefits program includes 160 hours of leave for personal time off and conference attendance, 100 hours of sick leave, and comprehensive health insurance. There is no financial support for moving and living expenses, but relocation information is provided that educational trainees find very beneficial.
What other support is available to the residents during the residency?
The Division of Pharmacy provides lab coats and scrubs to the residents. An office dedicated for pharmacy residents is provided with books and supplies as well as an individual desk, computer, and iPhone support. MD Anderson has its own medical library and also provides on-line access to the Texas Medical Center library both from within and outside of the institution. The institution also has its own medical graphics department to assist in the development of professional poster presentations, as well as a biostatistics department to assist with research endeavors.
What living arrangements are available for the resident?
Houston offers a wide variety of housing opportunities, including many apartments and townhouses near the Texas Medical Center. Many of the surrounding housing opportunities offer a regular shuttle service to the hospital or are close to the light rail system that goes through the Texas Medical Center
What entertainment and cultural opportunities are available in the Houston area?
Houston offers opportunities for enjoyment of the arts, entertainment, sports and recreation. The city offers major league sports, outstanding dining and shopping areas, as well as several special attractions, including the Johnson Space Center, Moody Gardens, the Houston Zoo, Houston Museum of Natural Science, Cynthia Mitchell Woods Pavilion, the Toyota Center, NRG Stadium, Minute Maid Park, Kemah Boardwalk, The Strand in Galveston, and the beaches of the Texas Gulf Coast.
Application Instructions
Application Deadline and Requirements:
- A pre-screening interview is required prior to application submission - Email the residency program director and attach CV prior to request a pre-screening interview. The deadline for making contact is one week after the end of the ASHP Midyear Clinical Meeting.
- Applications must be submitted via the Phorcas™ system
- Application must be submitted no later than January 5
- Participation in ASHP Resident Matching Program is required for all Residency Programs
- See the "International Visa Information" tab for more information regarding this
The following application materials must be submitted via the PhORCAS™ online application system by January 5th
- A Statement of Intent (not to exceed one typewritten page) describing your career goals and reasons for pursuing the residency program
- Curriculum Vitae
- Official transcript from Pharmacy College/University indicating date of graduation and degree earned (originals required via PhORCAS™)
- Reference Form in PhORCAS™ completed by THREE References
- MDACC requires comments to be made in all sections of the Recommendation Form in addition to the reference ratings section being completed
- No additional LORs are required
Interview Requirements and Scheduling:
- An interview is required.
- All candidates will be notified of their interview status by January 20
- Interviews will be conducted in February
Upon release of the match results, candidates who match with our institution will need to complete an institution specific application and requirements for appointment via the MD Anderson New Innovations© online application system. The New Innovations© system is a web-based database utilized to streamline the institution appointment process. More information about this process will be provided at the time of resident appointment.
For questions regarding the application process, please contact Morgan Mace, Director PGY2 Oncology Pharmacy Residency program via email PGY2-OncologyResidency@mdanderson.org or phone 713-563-0720.
MD Anderson does not discriminate on the basis of race, sex, color, national and ethnic origin, handicap, or age in administration of its administrative policies, admission policies, and other school administered programs. MD Anderson is a tobacco-free environment.
International Visa Information
Due to international visa approval processing timelines and restraints with our onboarding process, we are unable to sponsor or accommodate all visas for foreign pharmacy residency applicants. Please see below regarding specifications of each international visa:
• J-1 or H1-B: MD Anderson does not sponsor for pharmacists or pharmacy residents.
• TN-1 (Canadian and Mexican citizens): MD Anderson may be eligible for sponsorship provided the pharmacy resident meets all requirements. For more information, please contact the Residency Program Director.
• F-1 OPT (PGY1 residency candidates): In addition to MD Anderson not being able to sponsor pharmacy residents, the processing time to obtain F-1 OPT is not congruent with our onboarding/appointment process. Therefore, we are unable to accommodate residents with a F-1 OPT visa.
• F-1 STEM OPT (Current PGY1 residents seeking PGY2 residency): MD Anderson is unable to sponsor or accommodate pharmacy residents at this time.
If you have any questions, please contact the Residency Program Director.
Morgan Mace, Pharm.D., BCOP
Director, PGY2 Oncology Pharmacy Residency
The University of Texas
MD Anderson Cancer Center
1515 Holcombe Blvd – Unit 90
Houston, TX 77030-4009
Telephone: 713-563-0720
Email: mlmace@mdanderson.org